Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AGI 006 (r-baclofen) for functional dyspepsia
2005-000436-24Phase 2Completed
- Sponsor
- AGI Therapeutics plc
- Start
- Feb 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of baclofen in functional dyspepsia (FD) and dyspepsia (2 arms), sponsored by AGI Therapeutics plc. Started Feb 2005; status: completed.
02
Drugs
baclofen
03
Conditions
functional dyspepsia (FD)dyspepsia
Beyond the preview
Go deeper on 2005-000436-24.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-000436-24.